Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is a paper indexed in PICO Portal from OpenAlex.
How many citations does Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy have?
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has 83 citations in the OpenAlex counts PICO Portal stores.
When was Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy published?
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has 2018 year in the PICO Portal index.
What is the open-access status of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has bronze oa status in the PICO Portal index.
What is the DOI of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?
The DOI for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.
What is the PMID of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?
The PMID for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.
What is the OpenAlex record for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?
The OpenAlex for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.